Business Description
![Minerva Neurosciences Inc Minerva Neurosciences Inc logo](https://static.gurufocus.com/logos/0C0000ANI4.png?14)
Minerva Neurosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US6033801068
Description
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -0.72 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 5.7 | |||||
3-Year FCF Growth Rate | 29.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.55 | |||||
9-Day RSI | 48.68 | |||||
14-Day RSI | 52.32 | |||||
6-1 Month Momentum % | -52.23 | |||||
12-1 Month Momentum % | -68.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 12.58 | |||||
Quick Ratio | 12.58 | |||||
Cash Ratio | 12.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.4 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -54.62 | |||||
ROIC % | -156.45 | |||||
ROC (Joel Greenblatt) % | -185879.03 | |||||
ROCE % | -41.86 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | 0.58 | |||||
EV-to-EBITDA | 0.58 | |||||
EV-to-FCF | 0.64 | |||||
Earnings Yield (Greenblatt) % | 172.41 | |||||
FCF Yield % | -94.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NERV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Minerva Neurosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -4.48 | ||
Beta | -0.23 | ||
Volatility % | 117.27 | ||
14-Day RSI | 52.32 | ||
14-Day ATR ($) | 0.230786 | ||
20-Day SMA ($) | 3.267695 | ||
12-1 Month Momentum % | -68.31 | ||
52-Week Range ($) | 2.26 - 13.49 | ||
Shares Outstanding (Mil) | 6.99 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Minerva Neurosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Minerva Neurosciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Minerva Neurosciences Inc Frequently Asked Questions
What is Minerva Neurosciences Inc(NERV)'s stock price today?
The current price of NERV is $3.14. The 52 week high of NERV is $13.49 and 52 week low is $2.26.
When is next earnings date of Minerva Neurosciences Inc(NERV)?
The next earnings date of Minerva Neurosciences Inc(NERV) is 2024-08-01 Est..
Does Minerva Neurosciences Inc(NERV) pay dividends? If so, how much?
Minerva Neurosciences Inc(NERV) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |